Plasma Protein Binding Characteristics of Voriconazole

Universitaire Ziekenhuizen KU Leuven

Status: Completed

Conditions: Focus of the Study:Protein Binding Characteristics of Voriconazole.

Treatments: Other: Blood sampling

Study type: Observational

Funder types: Other

Identifiers

NCT01812473

ML8949

2013-000559-42 (EudraCT Number)

Details and patient eligibility

About

The purpose of this study is to investigate the influence of hypoalbuminemia on the protein binding characteristics of the antifungal drug voriconazole in ICU patients.

Enrollment: 35 patients

Sex: All

Ages: 2+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• treated with voriconazole

Exclusion criteria

• None

Trial design

35 participants in 1 patient group

Patients admitted to the Intensive Care Unit

Description:

All patients admitted to the Intensive Care Unit, treated with voriconazole are eligible for the study.

Treatment:

Other: Blood sampling